HomeBUSINESS
BUSINESS

Opdivo Drives Ono to Record Profits in FY2016
(May.15.2017)

Ono Pharmaceutical’s sales and profits reached all-time highs in the year ended March 2017 thanks to the strong performance of its immuno-oncology star Opdivo (nivolumab) in Japan and royalties from Bristol-Myers Squibb tied to the drug, the company said on May 11 ...
(LOG IN FOR FULL STORY)

News Calendar